IDO1 and neoplasm: Werfel et al.’s work (76) showed that efferocytosis and indoleamine-2,3-dioxygenase (IDO1, an immunomodulatory factor known to enhance maternal-fetal antigen tolerance, respectively) are two ways in which apoptotic and necrotic tumor cells promote tumor growth.